Urogen Pharma Stock Forecast

Buy or Hold candidate since Jun 08, 2026 Gain 28.40%

The UroGen Pharma Ltd stock price gained 4.23% on the last trading day (Monday, 22nd Jun 2026), rising from $33.57 to $34.99. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.90% from a day low at $33.70 to a day high of $35.35. The price has risen in 9 of the last 10 days and is up by 30.32% over the past 2 weeks. Volume fell on the last day by -231 thousand shares and in total, 604 thousand shares were bought and sold for approximately $21.13 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 63.10% during the next 3 months and, with a 90% probability hold a price between $48.31 and $61.92 at the end of this 3-month period.

URGN Signals & Forecast

The UroGen Pharma Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $31.92 and $28.74. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 31.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for UroGen Pharma Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $29.40 and $26.59. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, UroGen Pharma Ltd finds support just below today's level at $29.40. If this is broken, then the next support from accumulated volume will be at $26.59 and $26.25.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.65 between high and low, or 4.90%. For the last week, the stock has had daily average volatility of 5.13%.

The UroGen Pharma Ltd stock is extremely overbought on RSI14 (87). This increases the short-term risk substantially. Since the UroGen Pharma Ltd has been rising for 7 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Our recommended stop-loss: $34.02 (-2.76%) (This stock has high daily movements and this gives high risk. The RSI14 is 87 and this increases the risk substantially. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (URGN) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect UroGen Pharma Ltd to open at $34.68, and during the day (based on 14 day Average True Range), to move between $34.15 and $35.83, which gives a possible trading interval of +/-$1.68 (+/-4.92%) up or down from last closing price. If UroGen Pharma Ltd takes out the full calculated possible swing range there will be an estimated 4.92% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $29.40, some $5.59 (15.98%) from the current price of $34.99, our system finds the risk reward attractive.

Is UroGen Pharma Ltd stock A Buy?

UroGen Pharma Ltd holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $34.68 ( 0.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk